This startup offers whole genome sequencing and genetic testing services to identify health risks and inform personalized medicine. They provide genetic counseling and bioinformatics tools to patients and healthcare providers for accurate genetic analysis.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals lack access to comprehensive genetic information, hindering the ability to proactively manage their health and understand potential disease risks. Traditional genetic testing can be expensive and may not cover a wide range of potential genetic predispositions. This lack of accessible and comprehensive genetic data limits personalized medicine and preventative healthcare strategies.
Solution
Zarqa Genomics Lab (ZGL) offers a suite of advanced genomic testing services, including whole genome sequencing, whole exome sequencing, and targeted gene panels, to provide individuals and healthcare providers with detailed insights into genetic predispositions and potential health risks. By employing next-generation sequencing (NGS) technology and sophisticated bioinformatics tools, ZGL delivers accurate and comprehensive reports that can inform personalized treatment plans and preventative measures. ZGL's services cover a wide range of health areas, including oncology, cardiology, neurology, and infectious diseases, enabling proactive health management and improved patient outcomes. The company partners with leading international labs to ensure access to cutting-edge technologies and expertise.
Target Audience
ZGL's primary customers include individuals seeking proactive health management, healthcare providers looking to enhance diagnostic accuracy and personalize treatment plans, and researchers requiring comprehensive genomic data for their studies.
Features
- Whole Genome Sequencing (WGS) for comprehensive analysis of the entire genome
- Whole Exome Sequencing (WES) to focus on protein-coding regions with high clinical relevance
- Targeted gene panels for specific diseases and conditions, such as neurology, cardiology, and oncology
- Non-Invasive Prenatal Testing (NIPT) for early detection of chromosomal abnormalities in developing fetuses
- Advanced bioinformatics tools for accurate data analysis and interpretation
- Genetic counseling services to help patients and healthcare providers understand test results and make informed decisions
- Testing for a wide range of conditions including Ataxia, Epilepsy, Intellectual Disability, and Neuromuscular disorders
- Specialized testing for various medical fields including Physiotherapy, Cardiovascular health, Oncology, Pediatric Neurology, Endocrinology, Gynecology, Gastroenterology, Hepatology, Nephrology, and Infectious Diseases